Trial Profile
Phase I trial of FluCide influenza candidate, NV-INF-1.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2011
Price :
$35
*
At a glance
- Drugs NV INF 1 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors NanoViricides
- 08 Sep 2011 New trial record